Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Models for the Binding of Methotrexate to Escherichia coli Dihydrofolate Reductase

Direct Effect of Carboxylate of Aspartic Acid 27 upon Ultraviolet Spectrum of Methotrexate

H. BERNHARD SCHLEGEL, MARTIN POE and KARST HOOGSTEEN
Molecular Pharmacology July 1981, 20 (1) 154-158;
H. BERNHARD SCHLEGEL
Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN POE
Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KARST HOOGSTEEN
Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Ab initio molecular orbital calculations were performed on neutral and protonated 2,4-diamino-6-methylpteridine. The computations were repeated for the N-1-protonated molecule in a highly simplified model of the methotrexate binding site of Escherichia coli dihydrofolate reductase. The strengths of the ionic bond to Asp 27, the hydrogen bond to Thr 113, and the interaction with the peptide bonds between Ile 5 and Ala 6 and between Ala 6 and Ala 7 were calculated to be 100, 10, 5, and 1 kcal/mole, respectively, in the absence of solvent. These strengths suggest that the ionic bond is the most important component of the binding of protonated methotrexate. The energy calculations also provide a semiquantitative explanation of the hitherto unexplained shift to longer wavelength of the lowest-frequency UV absorbance band of N-1-protonated methotrexate upon binding to dihydrofolate reductase. This shift is due to a direct effect of the electrostatic field of the carboxylate ion of Asp 27 upon the molecular orbitals of the methotrexate.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 1
1 Jul 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Models for the Binding of Methotrexate to Escherichia coli Dihydrofolate Reductase
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Models for the Binding of Methotrexate to Escherichia coli Dihydrofolate Reductase

H. BERNHARD SCHLEGEL, MARTIN POE and KARST HOOGSTEEN
Molecular Pharmacology July 1, 1981, 20 (1) 154-158;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Models for the Binding of Methotrexate to Escherichia coli Dihydrofolate Reductase

H. BERNHARD SCHLEGEL, MARTIN POE and KARST HOOGSTEEN
Molecular Pharmacology July 1, 1981, 20 (1) 154-158;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
  • EIPA, HMA and SMN2 gene regulation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics